Arcutis Biotherapeutics, Inc.
US ˙ NasdaqGS ˙ US03969K1088

SecurityARQT / Arcutis Biotherapeutics, Inc.
InstitutionStemPoint Capital LP
Latest Disclosed Ownership413,792 shares
Latest Disclosed Value $ 9,748,940
StemPoint Capital LP ownership in ARQT / Arcutis Biotherapeutics, Inc.

On May 18, 2026 - StemPoint Capital LP filed a 13F-HR/A form disclosing ownership of 413,792 shares of Arcutis Biotherapeutics, Inc. (US:ARQT) valued at $9,748,940 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 224,740 shares of Arcutis Biotherapeutics, Inc.. This represents a change in shares of 84.12% during the quarter. The current value of the position is $9,082,734 USD.

StemPoint Capital LP has a history of taking positions in derivatives of the underlying security (ARQT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ARQT / Arcutis Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 ARCUTIS BIOTHERAPEUTICS COM 03969K108 413,792 189,052 84.12 9,749 49.37 1.8451
2026-05-15 2026-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 413,792 189,052 9,749 1.8933
2026-02-17 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 224,740 -187,153 -45.44 6,526 -15.95 1.1191
2025-11-14 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 411,893 206,221 100.27 7,764 169.30 1.5557
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 205,672 -234,401 -53.26 2,884 -58.11 0.9255
2025-05-15 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 440,073 -60,893 -12.16 6,883 -1.38 2.1940
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 500,966 -1,277,352 -71.83 6,978 -57.81 1.7421
2024-11-13 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 1,778,318 812,926 84.21 16,538 84.21 4.9513
2024-08-13 2024-06-30 13F/A-1 ARCUTIS BIOTHERAPEUTICS COM 03969K108 965,392 -1,240,507 -56.24 8,978 -58.93 2.6385
2024-08-13 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 965,392 -1,240,507 8,978 2.6264
2024-08-09 2024-03-31 13F/A-1 ARCUTIS BIOTHERAPEUTICS COM 03969K108 2,205,899 -388,637 -14.98 21,860 160.86 5.7781
2024-05-14 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 2,205,899 -388,637 21,860 5.7781
2024-02-13 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 2,594,536 2,594,536 8,380 2.2358
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 100,000 -93.65 42 -92.76 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 1,575,000 530.00 581 4,733.33 n/a n/a n/a
2024-11-13 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 250,000 -50.00 12 -96.57 n/a n/a n/a
2024-08-13 2024-06-30 13F/A ARCUTIS BIOTHERAPEUTICS COM Call 500,000 350 n/a n/a n/a
2024-08-13 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 5,000,000 350 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-13 2024-06-30 13F/A ARCUTIS BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 0 0 n/a n/a n/a
2024-08-09 2024-03-31 13F/A ARCUTIS BIOTHERAPEUTICS COM Put 825,000 516 n/a n/a n/a
2024-05-14 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 825,000 516 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.